NCT00777556View on ClinicalTrials.gov

Emergency Contraception Actual Use Study

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Emergency Contraception
Interventions
DRUG

DR-104

One 1.5 mg tablet of levonorgestrel for emergency contraception within 72 hours following unprotected sexual intercourse.

Trial Locations (5)

15213

Teva Investigational Site, Pittsburgh

19104

Duramed Research Investigational Site, Philadelphia

30303

Duramed Research Investigational Site, Atlanta

55404

Duramed Research Investigational Site, Minneapolis

94110

Duramed Research Investigational Site, San Francisco

Sponsors

Lead Sponsor

Duramed Research
All Listed Sponsors
lead

Duramed Research

INDUSTRY

NCT00777556 - Emergency Contraception Actual Use Study | Biotech Hunter | Biotech Hunter